Cargando…

Identification of early-induced broadly neutralizing activities against transmitted founder HIV strains

Broadly neutralizing antibodies have been proposed as key actors for HIV vaccine development. However, they display features of highly matured antibodies, hampering their induction by vaccination. As protective broadly neutralizing antibodies should be induced rapidly after vaccination and should ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lucas, Julie, Lin, Li-Yun, Paul, Nicodème, Laumond, Géraldine, Klingler, Jéromine, Schmidt, Sylvie, Frappier, Julia, Essat, Asma, Meyer, Laurence, Gordon, Alicia Castro, Goujard, C.é.cile, Bahram, Seiamak, Moog, Christiane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Basic Science: Concise Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794156/ https://www.ncbi.nlm.nih.gov/pubmed/36001527 http://dx.doi.org/10.1097/QAD.0000000000003371

Ejemplares similares

Distinct antibody profiles in HLA-B(∗)57(+), HLA-B(∗)57(−) HIV controllers and chronic progressors
por: Klingler, Jéromine, et al.
Publicado: (2022)

Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity
por: Mayr, Luzia M., et al.
Publicado: (2017)

Novel chimeric proteins mimicking SARS-CoV-2 spike epitopes with broad inhibitory activity
por: Cano-Muñoz, Mario, et al.
Publicado: (2022)

HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection
por: Rouers, Angeline, et al.
Publicado: (2017)

Sexually-Transmitted/Founder HIV-1 Cannot Be Directly Predicted from Plasma or PBMC-Derived Viral Quasispecies in the Transmitting Partner
por: Frange, Pierre, et al.
Publicado: (2013)

Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants
por: Martinez, David R., et al.
Publicado: (2020)

Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted / founder sensitivity to broadly neutralizing antibodies
por: Ratnapriya, Sneha, et al.
Publicado: (2023)

Neutralizing Antibodies Inhibit HIV-1 Infection of Plasmacytoid Dendritic Cells by an FcγRIIa Independent Mechanism and Do Not Diminish Cytokines Production
por: Lederle, Alexandre, et al.
Publicado: (2014)

Broadly neutralizing antibody-mediated protection against simian-HIV infection among macaques with vaginal sexually transmitted infections
por: Garber, David A., et al.
Publicado: (2023)

How HIV-1 Gag Manipulates Its Host Cell Proteins: A Focus on Interactors of the Nucleocapsid Domain
por: Klingler, Jéromine, et al.
Publicado: (2020)

Broad spectrum in vitro microbicidal activity of benzoyl peroxide against microorganisms related to cutaneous diseases
por: Okamoto, Kazuaki, et al.
Publicado: (2020)

Rate of broad-spectrum antibiotic overuse in patients receiving outpatient parenteral antibiotic therapy (OPAT)
por: Brenon, Jessa R., et al.
Publicado: (2021)

Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization
por: Su, Bin, et al.
Publicado: (2019)

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
por: Liao, Hua-Xin, et al.
Publicado: (2013)

Non-AIDS-Defining Events in Human Immunodeficiency Virus Controllers Versus Antiretroviral Therapy–Controlled Patients: A Cohort Collaboration From the French National Agency for Research on AIDS CO21 (CODEX) and CO06 (PRIMO) Cohorts
por: Manto, Carmelite, et al.
Publicado: (2023)

Exploring Highly Conserved Regions of SARS-CoV-2 Spike S2 Subunit as Targets for Fusion Inhibition Using Chimeric Proteins
por: Polo-Megías, Daniel, et al.
Publicado: (2022)

Multi-OMICS analyses unveil STAT1 as a potential modifier gene in mevalonate kinase deficiency
por: Carapito, Raphael, et al.
Publicado: (2018)

Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction
por: Foster, Toshana L., et al.
Publicado: (2016)

Does transient cART started during primary HIV infection undermine the long-term immunologic and virologic response on cART resumption?
por: Krastinova, Evguenia, et al.
Publicado: (2015)

A Case of Unusual Comedogenesis in Alopecia Totalis
por: Nikam, Balkrishna P., et al.
Publicado: (2022)

Electrical conductivity through π–π stacking in a two‐dimensional porous gallium catecholate metal–organic framework
por: Skorupskii, Grigorii, et al.
Publicado: (2022)

The treatment of Merkel cell carcinoma with immune checkpoint inhibitors: implications for patients with rheumatoid arthritis
por: Klee, Gina, et al.
Publicado: (2021)

The potential of the human immune system to develop broadly neutralizing HIV-1 antibodies: implications for vaccine development
por: Zhang, Yu, et al.
Publicado: (2013)

The Heterogeneous Allelic Repertoire of Human Toll-Like Receptor (TLR) Genes
por: Georgel, Philippe, et al.
Publicado: (2009)

Neutralizing antibody VRC01 failed to select for HIV-1 mutations upon viral rebound
por: Cale, Evan M., et al.
Publicado: (2020)

Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda
por: Naluyima, Prossy, et al.
Publicado: (2014)

Interferon-induced transmembrane protein-3 rs12252-C is associated with rapid progression of acute HIV-1 infection in Chinese MSM cohort
por: Zhang, Yonghong, et al.
Publicado: (2015)

Comparing genotoxic signatures in cord blood cells from neonates exposed in utero to zidovudine or tenofovir
por: Vivanti, Alexandre, et al.
Publicado: (2015)

Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection
por: Martin, Genevieve E., et al.
Publicado: (2017)

HLA-associated polymorphisms in the HIV-2 capsid highlight key differences between HIV-1 and HIV-2 immune adaptation
por: de Silva, Thushan I., et al.
Publicado: (2018)

Long-acting combination anti-HIV drug suspension enhances and sustains higher drug levels in lymph node cells than in blood cells and plasma
por: Kraft, John C., et al.
Publicado: (2017)

Additional boosting to the RV144 vaccine regimen increased Fc-mediated effector function magnitude but not durability
por: Shubin, Zhanna, et al.
Publicado: (2023)

Immunogenicity of tetanus, diphtheria and acellular pertussis vaccination among pregnant women living with and without HIV
por: Nunes, Marta C., et al.
Publicado: (2023)

HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site
por: McCurley, Nathanael P., et al.
Publicado: (2017)

Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma
por: Kumar, Amit, et al.
Publicado: (2018)

Epitope mapping of severe acute respiratory syndrome coronavirus 2 neutralizing receptor binding domain-specific monoclonal antibodies
por: Maghsood, Faezeh, et al.
Publicado: (2022)

Common evolutionary features of the envelope glycoprotein of HIV-1 in patients belonging to a transmission chain
por: Beretta, Maxime, et al.
Publicado: (2020)

Putting music to trial: Consensus on key methodological challenges investigating music‐based rehabilitation
por: Grau‐Sánchez, Jennifer, et al.
Publicado: (2022)

Translational regulation of APOBEC3G mRNA by Vif requires its 5′UTR and contributes to restoring HIV-1 infectivity
por: Guerrero, Santiago, et al.
Publicado: (2016)

HIV-1 Envelope Glycoprotein Amino Acids Signatures Associated with Clade B Transmitted/Founder and Recent Viruses
por: Kafando, Alexis, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_un3f27uess1a1perngemd3affa